Building up Resilience in a Pharmaceutical Supply Chain through Inventory, Dual Sourcing and Agility CapacityFlorian Lücker, Ralf W. Seifert2017-01-15articleOmega150 citationsgreenNo readable copy stored yet — this record is metadata only.Supply Chain Resilience and Risk ManagementSupply Chain and Inventory ManagementSustainable Supply Chain ManagementAbstractNo abstract was published for this record.Citations in this libraryStored only when both papers are in the corpus — 150 citations exist upstream.References2004Building the Resilient Supply Chain2006Perspectives in supply chain risk management2004Managing Risk To Avoid Supply-Chain Breakdown2006On the Value of Mitigation and Contingency Strategies for Managing Supply Chain Disruption Risks2005An Empirical Analysis of the Effect of Supply Chain Disruptions on Long‐Run Stock Price Performance and Equity Risk of the Firm2005Association Between Supply Chain Glitches and Operating Performance2018Government Accountability Office (GAO)2008Single or dual sourcing: decision-making in the presence of supply chain disruption risksCited by2021Retail supply chain network design with concurrent resilience capabilities2020Resilience building in service firms during and post COVID-192022Internet of Things (IoT)—blockchain-enabled pharmaceutical supply chain resilience in the post-pandemic era2022Towards increasing synergistic effects of resilience strategies in supply chain network design2018Decision modeling of risks in pharmaceutical supply chains2021Advancing the understanding of pharmaceutical supply chain resilience using complex adaptive system (CAS) theory2024Review of metrics to assess resilience capacities and actions for supply chain resilience2022Resilience capabilities of healthcare supply chain and supportive digital technologies